Evolus Stock (NASDAQ:EOLS)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$16.75

52W Range

$7.74 - $17.82

50D Avg

$16.25

200D Avg

$13.66

Market Cap

$1.04B

Avg Vol (3M)

$565.68K

Beta

1.31

Div Yield

-

EOLS Company Profile


Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

304

IPO Date

Feb 08, 2018

Website

EOLS Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Product$199.72M$146.59M$98.97M
Service$2.36M$2.02M-

Fiscal year ends in Dec 23 | Currency in USD

EOLS Financial Summary


Dec 23Dec 22Dec 21
Revenue$199.72M$148.62M$99.67M
Operating Income$-49.23M$-57.58M$-63.62M
Net Income$-61.69M$-74.41M$-46.81M
EBITDA$-70.21M$-59.50M$-64.28M
Basic EPS-$-1.33$-0.94
Diluted EPS-$-1.33$-0.94

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Jul 31, 24 | 10:22 PM
Q1 24May 07, 24 | 12:00 AM
Q4 23Mar 07, 24 | 10:40 PM

Peer Comparison


TickerCompany
SUPNSupernus Pharmaceuticals, Inc.
ITCIIntra-Cellular Therapies, Inc.
ANIPANI Pharmaceuticals, Inc.
PAHCPhibro Animal Health Corporation
IXHLIncannex Healthcare Limited
SSICSilver Spike Investment Corp.
DCPHDeciphera Pharmaceuticals, Inc.
PROCProcaps Group S.A.
PBHPrestige Consumer Healthcare Inc.
ALKSAlkermes plc
PCRXPacira BioSciences, Inc.
COLLCollegium Pharmaceutical, Inc.
EGRXEagle Pharmaceuticals, Inc.
AMPHAmphastar Pharmaceuticals, Inc.